← Back to patent-cliff list
Abacavir Sulfate
Tier C — Watch / tradeAbacavir Sulfate
Viiv Healthcare
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：RT
Brand：Ziagenavir, Virol, Ziagen
Indications (approved)：HIV infection
Regional status
US
Approved
1998-12-17
EU
Approved
1999-07-08
China
Approved
2002-02-20
Japan
Approved
1999-09-10
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Abacavir Sulfate?
Approved indications include: HIV infection.
When does the Abacavir Sulfate patent expire?
No public expiry year is available for Abacavir Sulfate yet; this page updates once verified.
How do I get a quote for Abacavir Sulfate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27